Buserelin - @ - Carcino-chemotherapeutic drugs
Drug Name:
Buserelin - @ - Carcino-chemotherapeutic drugs
List Of Brands:
Indication Type Description:
Indication:
Prostrate cancer
New drugs approved For Marketing by Drug Controller General of India(DCGI )
during the period January 1988 to November 2014
(Ref- IDMA Annual Publication 2015)
Name of Drug Indication Date of Approval
1.Buserelin acetate injection 1mg/ml 08-090-2010
Indicated for the palliative(initial and maintenance treatment) of
patients with hormone dependent advanced carcinoma of the
prostrate gland (stage D)
Dosages/ Overdosage Etc:
Indicated for the palliative(initial and maintenance treatment) of
patients with hormone dependent advanced carcinoma of the
prostrate gland (stage D)
Patient Information:
Buserilin - systemic
1.Allergies-
Tell your doctor if you are have ever had any unusual or allergic reaction to
buserelin.
2.Pregnancy-
Buserilin causes sterility which may be permanent. If you intent to have children,
discuss this with your doctor before receiving the medicine
3.Older adults-
Many medicines have not been studied specifically in older people. Therefore,
it may not be known whether they work exactly the same way than they do in
younger adults, or if they cause different side effects or problems in older people.
There is no specific information comparing use of buserilin in the elderly with use
in other age groups, it has been used mostly in elderly patients and is not
expected to cause different side effects or problems in older people than it
does in younger adults.